PharmDLive
Clinical pharmacists + AI. Better outcomes.
Miami, FL, UK
PharmDLive is involved in a technology integration partnership with MyMonitor.ai, an AI-powered dermatology and clinical research platform.
Problem Statement
Traditional methods for dermatological lesion detection can be slow or lack consistent accuracy, particularly across diverse skin types.
Core Technology
AI and Multispectral Imaging
Key Differentiators
Achieves κ > 0.90 agreement with board-certified dermatologists, exceeding clinical validation standards; Processes skin analysis in under 5 seconds using multispectral imaging technology; Melanin-aware lesion detection
Clinical Focus
Lesion Detection; Clinical Research
Company Info
- Business Model
- SaaS
- Total Funding
- 1,000,000
- Website
- pharmdlive.com
Categories
Technologies
Clinical & IP
Clinical Validation
Case study: 3,233 heart failure ED visits showed 11.2% reduction in avoidable admissions, $3.35M cost savings annually. Platform targets 88 MIPS/APM quality measures, ACO/HEDIS standards. Evidence-based interventions per diabetes prevention protocols.
MedStartr Index Score
?What do you think of PharmDLive?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.